Organon Zemuron supply
Executive Summary
Organon's supply problems with the neuromuscular blocking agent Zemuron (rocuronium) have been resolved, according to the Center for Drug Evaluation & Research's drug shortages website. Zemuron 5 mL and 10 mL vials for injection have been in shortage since April 2004 due to manufacturing problems; the product is manufactured in the U.S. by Baxter. Supplies were expected to be normalized by fall 2004...
You may also be interested in...
EU ‘Structured Dialog’ Offers Opportunity To Secure Supply
A “structured dialog” led by the European Commission with pharmaceutical industry stakeholders provides a critical opportunity to address weaknesses in the stability and security of the supply chain by improving the environment for local manufacturing, Medicines for Europe believes.
Adcock Struggles As South African Healthcare Awaits Relief
Despite a slight increase in revenue, South Africa’s Adcock continues to struggle as it reports a continued drop in gross profit. The company expects the economy to remained constrained due to COVID-19, but is eagerly anticipating recovery with the government’s vaccine roll-out.
EMEA Round-Up: Bayer Strikes Egypt Deals, Orkla Acquires NutraQ, Uriach Grabs Sidroga
Round-up of the latest news across EMEA, including two deals for Bayer in Egypt and Saudi Arabia; Orkla's acquisition of NutraQ; and Uriach's deal for Sidroga.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: